Tuesday, October 3, 2023 | Back issues
Courthouse News Service Courthouse News Service

Biotech Antitrust

WILMINGTON, Del. - Human Genome Sciences claims Genentech colluded with (nonparty) Celltech R&D to monopolize the market for producing monoclonal antibody therapeutics using recombinant DNA.

Categories / Uncategorized

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.